Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Moderate Buy” from Brokerages

Chronological Source Flow
Back

AI Fusion Summary

Disc Medicine, Inc. (NASDAQ:IRON) has a consensus “Moderate Buy” rating from 12 research firms—10 buy, one hold, one sell. The average 1‑year target price is $104.80; TD Cowen reaffirmed a buy, while BMO cut its target to $100, outperform stance.
#Disc Medicine #Moderate Buy #Target Price #TD Cowen #BMO Capital Markets #NASDAQ:IRON #Equity Research
30/03 09:38 defenseworld.net
3 Πηγές

Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of “Moderate Buy” from Brokerages

Disc MedicineModerate BuyTarget PriceTD CowenBMO Capital MarketsNASDAQ:IRON
30/03 09:54 defenseworld.net

Warner Music Group Corp. (NASDAQ:WMG) Receives Consensus Rating of “Moderate Buy” from Brokerages

CONSENSUS RATING ARTICLESECONOMYPOLITICSCOMPANIES
30/03 11:16 defenseworld.net

Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of “Moderate Buy” from Brokerages

COMPANIESPOLITICSCONSENSUS RATING ARTICLES
Comments
Loading...
0